Cutting down on lung cancer: Ecliptasaponin A is a novel therapeutic agent

Department of Health Sciences, Public University of Navarre, Pamplona, Spain Correspondence to: Mirja Rotinen, PhD; Ignacio Encío, PhD. Av. Barañain S/N, 31008 Pamplona, Spain. Email: mirja.rotinen@unavarra.es; ignacio.encio@unavarra.es. Provenance and Peer Review: This article was commissioned by the editorial office, Annals of Translational Medicine. The article did not undergo external peer review. Comment on: Han J, Lv W, Sheng H, et al. Ecliptasaponin A induces apoptosis through the activation of ASK1/JNK pathway and autophagy in human lung cancer cells. Ann Transl Med 2019;7:539.